---
source: congress
document_id: "s355"
title: "FDA Modernization Act 3.0"
agencies: []
published: Wed, 17 Dec 2025
fetched: 2025-12-19
type: s
category: regulatory-pathway
relevance: high
url: https://www.govtrack.us/congress/bills/119/s355
---

## Summary
The FDA Modernization Act 3.0 likely aims to update regulatory frameworks for drug development and medical innovation. It potentially streamlines clinical trial processes or introduces new guidelines for emerging medical technologies.

## Startup Angle
A potential startup opportunity could be a clinical trial optimization platform that helps pharma and biotech companies navigate new regulatory pathways more efficiently. Companies like TrialSpark or Medable might benefit from clearer regulatory guidelines around digital clinical trial methodologies.

## Key Details
- **Type:** s
- **Agencies:** 
- **Published:** Wed, 17 Dec 2025
- **Source:** [congress](https://www.govtrack.us/congress/bills/119/s355)

- **Sponsor:** 
- **Latest Action:** Bill Text: This bill's text for status <Passed the Senate> (Dec. 17, 2025) is now available.


